Role of estrogen in the regulation of cholesteryl ester synthesis in macrophages: The interaction between native and modified low density lipoprotein and human monocyte-derived macrophages

Clinical Biochemistry

Volumn 35, Issue 8, 2002, Pages 597-605

  Napolitano, Mariarosaria ^a   Calcabrini, Annarica ^a   Botham, Kathleen M ^b   Bravo, Elena ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Cholesterol esterification; Estrogen; Human monocyte derived macrophages; LDL receptor expression; Modified LDL; Signal transduction

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ESTRADIOL; ESTROGEN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTICLE; CELL MATURATION; CHOLESTEROL ESTERIFICATION; CHOLESTEROL SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; FOAM CELL; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ESTROGENS; HUMANS; MACROPHAGES; MONOCYTES; RECEPTORS, CELL SURFACE;

EID: 12244282447     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(02)00404-6     Document Type: Article

References (49)

1. Mendelsohn M.E., Kara R.H. Estrogen and the blood vessel wall. Curr Opin Lipidol. 9:1994;619-626.
2. Farhat M.Y., Lavigne M.G., Ramwell P.W. The vascular protective effects of estrogen. FASEB J. 10:1996;614-624.
3. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., Allan J.D. Postmenopausal hormone replacement therapy scientific review . JAMA. 288:2002;872-881.
4. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results From the Women's Health Initiative randomized controlled trial . JAMA. 288:2002;321-333.
5. Cid M.C., Schnaper H.W., Kleinman H.K. Estrogens and the vascular endothelium. Ann N Y Acad Sci. 966:2002;143-157.
6. Zhu X.D., Meekins D., Bonet B., Knopp R.H. Effect of sex hormones on susceptibility of low density lipoprotein to copper mediate oxidative modification. Clin Res. 41:1993;26A.
7. Sack M.N., Rader D.J., Cannon R.O. Oestrogen and inhibition of oxidative modification of low density lipoproteins in post-menopausal women. Lancet. 343:1994;269-274.
8. Song J., Wan Y., Rolfe B.E., Campbell J.H., Campbell G.R. Effect of estrogen on vascular smooth muscle cells is dependent upon cellular phenotype. Atherosclerosis. 140:1998;97-104.
9. St. Clair R.W. Effects of estrogens on macrophage foam cells: a potential target for the protective effect of estrogens on atherosclerosis. Curr Opin Lipidol. 8:1997;281-286.
10. Enserink M. Women's health. The vanishing promises of hormone replacement. Science. 297:2002;325-326.
11. Gerrity R.G. The role of monocytes in atherosclerosis I Transition of blood-borne monocytes into foam cells in fatty lesions . Am J Pathol. 103:1981;181-190.
12. Wagner J., Clarkson T.B., St. Clair R.W., Schwenke D.C., Shively C.A., Adams M.R. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomologous monkeys. JClin Invest. 88:1991;1995-2002.
13. McCrohon J.A., Nakhla S., Jessup W., Stanley K.K., Celermajer D.S. Estrogen and progesterone reduce lipid accumulation in human monocyte-derived macrophages. Circulation. 100:1999;2319-2325.
14. Frazier-Jessen M.R., Kovacs E.J. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol. 154:1995;1838-1846.
15. Haarbo J., Nielsen L.B., Stender S., Christiansen C. Aortic permeability to LDL during estrogen therapy: a study in normocholesterolemic rabbits. Arterioscler Thromb. 14:1994;243-247.
16. Koo C., Wernette-Hammond M.E., Garcia Z., et al. Uptake of cholesterol-rich remnant lipoproteins by human monocyte- derived macrophages is mediated by low density lipoprotein receptors. J Clin Invest. 8:1988;1332-2325.
17. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA. 7:1979;333-337.
18. Steinbrecher U.P. Receptors of oxidized low density lipoprotein. Biochim Biophys Acta. 1436:1999;279-298.
19. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New Engl J Med. 320:1989;915-922.
20. Endemann G., Stanton L.W., Madden K., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidised low density lipoprotein. J Biol Chem. 268:1993;11811-11816.
21. Han J., Hajjar D.P., Febbraio M., Nicholson A.C. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem. 272:1997;21654-21659.
22. Katzenellenbogen B.S. Estrogen receptors bioactivities and interactions with cell signalling pathways . Biol Reprod. 54:1996;287-293.
23. Farhat M.Y., Abi-Younes S., Ramwell P.W. Non genomic effect of estrogen and the vessel wall. Biochem Pharmacol. 51:1996;571-577.
24. Chait A., Mazzone T. Autoregulation of the modified low density lipoprotein receptor in human monocyte-derived macrophages. Arteriosclerosis. 2:1982;134-141.
25. Berthois Y., Katzenellenbogen J.A., Katzenellenbogen B.S. Phenol red in tissue culture is a weak estrogen implication concerning the study of estrogen -responsive cells in culture . Proc Natl Acad Sci 1986 USA. 83:1986;2496-2500.
26. Eckert R.L., Katzenellenbogen B.S. Physical properties of estrogen receptor compexes in MCF-7 human breast cancer cells: difference with anti-estrogen and estrogen. J Biol Chem. 257:1982;8840-8846.
27. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1955;1345-1352.
28. Basu S.K., Goldstein J.L., Anderson R.G.W., Brown M.S. Degradation of cationized lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA. 73:1976;3178-3182.
29. Gebicki J., Jurgens G., Esterbauer H. Oxidation of low density lipoprotein in vitro. Sies H. Oxidative stress. 1991;371-397 Academic Press, London.
30. Esterbauer H., Striegl G., Phil H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun. 6:1986;67-75.
31. Guldur T., Bravo E., Botham K.M., Cantafora A., Mayes P.A. Enhanced hepatic uptake and metabolism of desialylated chylomicrons. Nutr Metab Cardiovasc Dis. 7:1997;415-424.
32. Basu S.K., Goldstein J.L., Brown M.S. Receptor-mediated endocytosis of low density lipoprotein in cultured cultured cells. Methods Enzymol. 46:1986;241-261.
33. Brown M.S., Goldstein J.L. Lipoprotein metabolism in the macrophages implications for cholesterol deposition in atherosclerosis . Annu Review Biochem. 52:1983;223-261.
34. Bradford M. A sensitive method for quantitation of microgram quantities of protein utilizing the principle of dye-binding. Anal Biochem. 72:1976;248-252.
35. Barter P.J., Rye K.A. Molecular mechanism of reverse cholesterol transport. Curr Opin Lipidol. 7:1996;82-87.
36. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 23:1986;305-309.
37. Hough J.L., Zilversmit D.B. Effect of 17 beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis. 6:1986;57-63.
38. Adams M.R., Kaplan J.R., Manuck S.B., et al. Inhibition of coronary artery atheroscerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis. 10:1990;1051-1057.
39. Seeger H., Wallwiener D., Mueck A.O. Effect of medroprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells. Menopause. 8:2001;5-9.
40. Sulistiyani R.W., St Clair R.W. Effects of 17-estradiol on metabolism of acetylated low-density lipoprotein by THP-1 macrophages in culture. Arterioscler Thromb Vasc Biol. 17:1997;1691-1700.
41. Henkin R.I., Casper A.G.T., Brown R., Harlan A.B., Bartter F.C. Presence of cortocosterone and cortisol in the central and peripheral nervous system of the cat. Endocrinology. 82:1968;1058-1061.
42. Contreras J.A., Lasuncion M.A. Essential differences in cholesteryl ester metabolism between human monocyte-derived and J774 macrophages. Arterioscler Thromb. 14:1994;443-452.
43. Andreesen R., Osterholz J., Bodemann H., Bross K.J., Costabel U., Lohr G.W. Expression of transferrin receptors and intracellular ferritin during terminal differentiation of human monocytes. Blood. 49:1984;195-202.
44. Folgelman A.M., Haberland M.E., Seager J., Hokom M., Edwards P.A. Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J Lipid Res. 22:1981;1131-1141.
45. Gulshan S., McCruden A.B., Stimson W.H. Oestrogen receptors in macrophages. Scand J Immunol. 31:1990;691-697.
46. Danel L., Souweine G., Monier J.C., Saez S. Specific estrogen binding sites in human lymphoid cells and thymic cells. J Steroid Biochem. 18:1983;559-563.
47. Napolitano M., Blotta I., Montali A., Bravo E. 17-estradiol enhances the flux of cholesterol through the cholesteryl ester cycle in human macrophages. Bioscience Reports. 21:2001;637-652.
48. Hsu H.Y., Hajjar D.P., Khan F., Falcone D. Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway. J Biol Chem. 273:1998;1240-1246.
49. Mendez A.J. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem. 266:1991;10104-10109.